{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-23-000015","form_type":"8-K/A","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.265601+00:00","generated_at":"2026-06-18T23:03:05.714051+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merit Medical Q4 2022 revenue $293.4M (+5.4% YoY); GAAP EPS $0.58 vs $0.36; issues FY2023 guidance","bullets":["Q4 revenue $293.4M, up 5.4% YoY; constant currency organic revenue up 8.2%.","GAAP operating margin 10.4% (vs 7.9% Q4 2021); non-GAAP operating margin 17.8% (vs 17.4%).","GAAP EPS $0.58 (vs $0.36); non-GAAP EPS $0.79 (vs $0.71).","Issued fiscal year 2023 guidance; specific numbers not disclosed in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-23-000015","json":"https://secwatch.observer/filing/0000856982-23-000015.json","markdown":"https://secwatch.observer/filing/0000856982-23-000015.md","text":"https://secwatch.observer/filing/0000856982-23-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000015/0000856982-23-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000015/mmsi-20230228x8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:03:05.714051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c43b7a432d4a6fd41fa5c2c4550f436fa2d9bb7","claim":"MERIT MEDICAL SYSTEMS INC reported the fourth quarter ended December 31, 2022 results: revenue $293.4 million, EPS $0.58. Guidance initiated.","evidence_excerpt":"● Q4 2022 reported revenue of $293.4 million, up 5.4% compared to Q4 2021 ● Q4 2022 constant currency revenue, organic* up 8.2% compared to Q4 2021 ● Q4 2022 GAAP operating margin of 10.4%, compared to 7.9% in Q4 2021 ● Q4 2022 non-GAAP operating margin* of 17.8%, compared to 17.4% in Q4 2021 ● Q4 2022 GAAP EPS $0.58, compared to $0.36 in Q4 2021","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000015/0000856982-23-000015-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$293.4 million"},{"label":"EPS","value":"$0.58"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"fefc5a36c2a2d2a4a3871e69fe751b97c25fb94f","claim":"MERIT MEDICAL SYSTEMS INC updated its the year ended December 31, 2022 guidance (initiated).","evidence_excerpt":"On February 22, 2023, the Company issued a press release announcing its operating and financial results for the quarter and year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698223000015/0000856982-23-000015-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}